These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8129391)

  • 1. [Portal-transfer of an orally administered anti-cancer agent analysis of the time course of portal blood and systemic blood levels of preoperatively administered UFT].
    Yoshikawa K; Hashimoto T; Yamaguchi T; Dousei T; Moriguchi S; Taniguchi M; Ueda H; Taketani S; Utsumi T; Suhara H
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):501-5. PubMed ID: 8129391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases].
    Yoshikawa K; Iwasaki T; Amemiya A; Emoto T; Fujii M; Han N; Itou A; Tsujimura T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1333-7. PubMed ID: 2114828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of pre-operative chemotherapeutic methods for colonic cancer--the concentration in blood and tissues after pre-operative administration of UFT].
    Sawa H; Fujii M; Sakabe T; Tanaka T
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2277-81. PubMed ID: 1929448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
    Tanimura T; Kaneshige E; Fujiwara K; Kobashi Y; Inoue K; Kono I; Sekiba K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of long-term administration of oral anti-cancer agent].
    Watanabe H; Sakakibara N
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):637-42. PubMed ID: 8470922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
    J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer].
    Maruyama S; Maruyama M; Kato K; Koide A; Ohbu M; Hasegawa K; Takashima I; Ebuchi M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1743-5. PubMed ID: 15553701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
    Tomita T; Tajima T; Ishibashi M; Tagaya N; Aoki H; Itoh S; Kadowaki A; Kogure H; Tajima Y
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3755-62. PubMed ID: 2512859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
    Suda Y; Uchida K; Okamura H; Oshima Y; Shimizu M; Miyakawa T; Okubo S; Shiina E; Hosoda Y; Tokura Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2181-7. PubMed ID: 1444484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamic change of serum UFT concentration in a patient with tongue cancer complicating chronic renal failure].
    Yanagisawa T; Arimoto T; Kishimoto H; Takahashi Y; Urade M; Yoshioka W
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):553-6. PubMed ID: 7887648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
    Inaba S; Kondo Y; Tsuchiya K; Kawai K; Ogino A; Umeda T; Ueda Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2175-80. PubMed ID: 1444483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
    Oguma S; Sakai K; Sato R; Ouchi K; Owada Y; Sato T
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1122-8. PubMed ID: 3032114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
    Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
    Hasegawa S; Matsumoto S; Kawashima K; Fujii H; Hatano E; Satoh S; Ikai I; Shimahara Y
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1045-9. PubMed ID: 16044971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
    Iida A; Takagi R; Hoshina H; Ono K; Kaji M; Tsurumaki H; Fukuda J; Nagashima K; Miyaura Y; Hayatsu M; Miyamoto T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1527-32. PubMed ID: 11015997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effect of UFT against differentiated thyroid cancer].
    Suzumura K; Koike A; Naruse T; Matsumoto K; Nagata H; Kojima T; Kanemitsu T; Katoh K
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2485-9. PubMed ID: 7944495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5-FU concentration in the blood and tissue of patients with gastric and colorectal cancer after administration of UFT or tegafur].
    Arima S; Futami K; Shigeta M; Kinashi M; Shimura H
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2618-24. PubMed ID: 3090940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.